Back to School: How biopharma can reboot drug development. Access exclusive analysis here

0910 MiNA
BioCentury & Getty Images

Finance

MiNA raises £23M in first venture round 12 years after launch

Sep 10, 2020 | 9:56 PM GMT

After financing itself for 12 years via high-net-worth individuals and Sosei, London-based MiNA has tapped a traditional VC to lead its series A round to expand

Read the full 460 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE